Neurana Pharmaceuticals
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(858) 756-2480Website
www.neuranapharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Neurana Pharmaceuticals
Neurana Pharma is a biopharmaceutical company focused on developing innovative therapies for patients suffering from neurological disorders. Their primary product is a novel treatment aimed at alleviating acute migraine pain. The company targets healthcare providers and patients seeking effective solutions for migraine management. Neurana Pharma is committed to improving the quality of life for individuals affected by debilitating neurological conditions.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neurana Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Neurana Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Neurana Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Neurana Pharmaceuticals
Neurana Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Neurana Pharmaceuticals has new funding data
Product Launch: Get notified when Neurana Pharmaceuticals launches new products
Check if Neurana Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Neurana Pharmaceuticals is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Neurana Pharmaceuticals as Masked Content
Find more new buyers
Compare Similar Companies to Neurana Pharmaceuticals
Compare insights from companies similar to Neurana Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Neurana Pharmaceuticals
<$5M
11-50
Private
$69M
2013
N/A
Company Profile Activity
Activity Insights
Neurana Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neurana Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neurana Pharmaceuticals.
Neurana Pharmaceuticals financials insights
Gather financial insights about Neurana Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Private Equity
$9M
Series A
$60M
Neurana Pharmaceuticals Tech Stack
A closer look at the technologies used by Neurana Pharmaceuticals
See more technologies
Neurana Pharmaceuticals News & Media
Neurana Pharmaceuticals Completes Patient Enrollment in Phase 3 RESUME-1 Study
SAN DIEGO, Nov. 29, 2021 /PRNewswire/ -- Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced it has completed enrollment of its 1,000 patient Phase 3 RESUME-1 Study of tolperisone for the relief of muscle spasm associated...Neurana Pharmaceuticals to Present at Wells Fargo Virtual Healthcare Conference
SAN DIEGO, Sept. 2, 2021 /PRNewswire/ -- Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced that Craig Thompson, President and Chief Executive Officer, will present at the Wells Fargo Virtual Healthcare Conference and...Neurana Pharmaceuticals to Present at Napa Pain Conference and PAIN Week
SAN DIEGO, Calif., Aug. 30, 2021 /PRNewswire/ -- Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced the presentation of scientific abstracts at two congresses, the 28th Annual Napa Pain Conference August 27-28th, 2021,...Neurana Pharmaceuticals to Participate at the SVB Leerink Conference
SAN DIEGO, July 19, 2021 /PRNewswire/ -- Neurana Pharmaceuticals, Inc., a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced participation at the SVB Leerink Biopharma Private Company Connect. The conference takes place virtually...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neurana Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Neurana Pharma is a biopharmaceutical company focused on developing innovative therapies for patients suffering from neurological disorders. Their primary product is a novel treatment aimed at alleviating acute migraine pain. The company targets healthcare providers and patients seeking effective solutions for migraine management. Neurana Pharma is... Read More
